Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 63629-2240

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide (NDC 63629-2240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636292240)

This is a medication containing Olmesartan Medoxomil, Amlodipine Besylate and Hydrochlorothiazide. Each tablet contains 40mg of Olmesartan Medoxomil, 13.9 mg of Amlodipine Besylate, and 12.5 mg of Hydrochlorothiazide. The medication should be stored in a tight, light-resistant container with a child-resistant closure, at 20° to 25° C (68° to 77° F), with excursions permitted to 15° to 30° C (59° to 86° F). It is important to keep this medication out of the reach of children. This medication is prescription only and is supplied in a pack of 90 tablets.*

FDA Label Image

Olmesartan Medoxomil (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 1)

FDA Label Image

Amlodipine Besylate (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 2)

FDA Label Image

Hydrochlorothiazide (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 3)

FDA Label Image

Figure 1 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 4)

FDA Label Image

Figure 2 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 5)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.